Juwono S, Milloy MJ, Choi JC, Fairbairn N, Nolan S, Socías ME Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids AIDS PubMed

Lake S, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ Methadone dose, cannabis use, and treatment retention: findings from a community-based sample of people who use unregulated drugs J Addict Med PubMed

Pilarinos A, Kwa Y, Joe R, Thulien M, Buxton J, DeBeck K, Fast D Navigating opioid agonist therapy among young people who use illicit opioids in Vancouver, Canada Int J Drug Policy PubMed

El-Akkad S, Nolan S, Hayashi K, Dong H, Milloy MJ, DeBeck K, Ti L Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada J Addict Dis PubMed

Socías ME, Wood E, Le Foll B, Lim R, Choi JC, Mok WY, Bruneau J, Rehm J, Wild TC, Bozinoff N, Hassan A, Jutras-Aswad D, OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial Addiction PubMed

Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Bruneau J, Fischer B, Rehm J, Wild TC, Wood E, Brissette S, Gagnon L, Fikowski J, Ledjiar O, Masse B, Socías ME, OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse Flexible buprenorphine/naloxone model of care for reducing opioid use in individuals with prescription-type opioid use disorder: an open-label, pragmatic, noninferiority randomized controlled trial Am J Psychiatry PubMed

Pilarinos A, Bromberg DJ, Karamouzian M Centering young people's perspectives, needs, and preferences in research regarding barriers to medications for opioid use disorder-Reply JAMA Pediatr PubMed

Mitra S, Grant C, Nolan S, Mohd Salleh NA, Milloy MJ, Richardson L Assessing the temporality between transitions onto opioid agonist therapy and engagement with antiretroviral therapy in a cohort of HIV-positive people who use opioids daily AIDS Behav PubMed